Male circumcision for the prevention of acquisition and transmission of sexually transmitted infections: the case for neonatal circumcision.
The American Academy of Pediatrics (AAP) male circumcision policy states that while there are potential medical benefits of newborn male circumcision, the data are insufficient to recommend routine neonatal circumcision. Since 2005, however, 3 randomized trials have evaluated male circumcision for prevention of sexually transmitted infections. The trials found that circumcision decreases human immunodeficiency virus acquisition by 53% to 60%, herpes simplex virus type 2 acquisition by 28% to 34%, and human papillomavirus prevalence by 32% to 35% in men. Among female partners of circumcised men, bacterial vaginosis was reduced by 40%, and Trichomonas vaginalis infection was reduced by 48%. Genital ulcer disease was also reduced among males and their female partners. These findings are also supported by observational studies conducted in the United States. The AAP policy has a major impact on neonatal circumcision in the United States. This review evaluates the recent data that support revision of the AAP policy to fully reflect the evidence of long-term health benefits of male circumcision.
Tobian
Aaron A R
AA
Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Gray
Ronald H
RH
Quinn
Thomas C
TC
D002944:Circumcision, Male / Q000941:ethics; D005260:Female; D015658:HIV Infections / Q000517:prevention & control / Q000635:transmission; D006558:Herpes Genitalis / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D008297:Male; D012749:Sexually Transmitted Diseases / Q000517:prevention & control* / Q000635:transmission; D014245:Trichomonas Infections / Q000517:prevention & control; D016585:Vaginosis, Bacterial / Q000517:prevention & control